Corporate Banner
Satellite Banner
Genotyping & Gene Expression
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Better Living through Proteomics

Published: Monday, September 09, 2013
Last Updated: Monday, September 09, 2013
Bookmark and Share
As a patient facing illness, knowing what’s ailing you can bring peace of mind and, more importantly, can inform treatment decisions.

For neglected infectious diseases, accurate diagnostic tools can be revolutionary, saving lives and shaping the health of entire communities.

One of these neglected diseases is human African trypanosomiasis (HAT). Also known as African sleeping sickness, HAT is a debilitating infection that affects thousands each year. Patients are often only diagnosed in the late stage of the disease by observing the parasites in cerebrospinal fluid, after the parasite has entered the central nervous system and caused grave illness. A low-cost, rapid “dipstick” test that could analyze a drop of patient’s blood and diagnose the illness early would make a huge impact.

Researchers have spent decades looking for proteins from the parasite itself in plasma, the liquid component of blood, with the goal of developing rapid diagnostic tests. While plasma represents an ideal source of biomarkers – a simple finger-prick is sufficient for testing – the fluid has a major flaw when it comes to diagnosis: it’s a murky soup of proteins, ranging from abundant ones such as albumin and globulins to scarcer ones such as proteins from infectious organisms.

Scientists in the Broad’s Proteomics Platform have recently developed and optimized analytic methods that, for the first time, can identify parasite proteins in the plasma of infected patients. The sophisticated approach overcomes what research scientist Rushdy Ahmad calls a “mismatch in dynamic range,” by effectively “zooming in” on the proteins they’re most interested in.

He explains that the dynamic range of proteins in plasma, meaning the lowest to highest abundance, is perhaps as great as 12 orders of magnitude. In other words, the most abundant proteins are 1 trillion times more numerous than the least abundant proteins. The dynamic range of a mass spectrometer – the gold standard for analyzing proteins – is much narrower, only 4 orders of magnitude. Running plasma through a mass spectrometer will only reveal the most abundant proteins, leaving the scarcer ones hidden below the threshold of detection.

In the new method, plasma is first “immunodepleted,” removing the top 50-70 most abundant human plasma proteins, including proteins such as albumin. “We want to collapse that dynamic range,” Ahmad explains. The technique is like skimming off the fat from soup to leave the nutritious broth, vegetables, and meat. The remaining sample is then “fractionated,” breaking it into 30 smaller samples, each containing proteins of a narrower range of abundance. “Those fractions are what we inject into the mass spectrometer,” he says. “The combination of abundant protein removal and subsequent fractionation enabled the mass spec to probe deeper into the proteome, beneath all the human proteins we’re not interested in.”

In collaboration with Terry Pearson and colleagues at the University of Victoria in British Columbia, Ahmad and platform director Steve Carr applied the new method to plasma samples from patients infected with African sleeping sickness. They were able to identify more than 250 proteins from the trypanosome parasites that underlie this dangerous disease, showing promise for the method to discover biomarkers of disease in plasma that could one day be incorporated into a diagnostic test.

More work remains before African sleeping sickness can be rapidly diagnosed in the field. The researchers must learn which of the 250 proteins make the best biomarkers to develop a diagnostic test against. In addition, the samples used in this study came from patients with late stage disease, and the team hopes to identify proteins present during early stages of infection, so they are working to get more samples from the field. They may also forge a partnership with a diagnostic company to actually create the assay.

Interestingly, the study detected more than 4000 low-abundance human proteins present in the plasma, the greatest depth of coverage of the human plasma proteome to date. Carr, Ahmad, and their colleagues are currently mining data on these thousands of proteins found in plasma to look for patterns of change during illness – signatures of host response – in diseases such as tuberculosis and malaria. Those signatures could then form the basis for new a diagnostic approach, which would use patterns of change in the levels of proteins as indicators of disease. The proteomic analysis of human plasma proteins also provides a window into disease biology and insights that could guide vaccine development.

The researchers also plan to investigate other illnesses that could benefit from improved diagnosis, such as another trypanosome illness, Chagas disease, or cancers with poor diagnostics, like lung cancer, in addition to other neglected diseases. “Now this opens up the door for all these other diseases that don’t get a lot of limelight because they’re out on the periphery,” he says. “For now, the science is progressing and this work shows the technological capability for discovery.”


Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,500+ scientific posters on ePosters
  • More than 3,700+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

GTEx: Useful Expression For Cancer Research
GTEx Project has recently published several papers reporting on findings from its two-year pilot phase.
Tuesday, May 26, 2015
Two Studies Identify A Detectable, Pre-Cancerous State In The Blood
Findings pave way for new lines of cancer research focused on detection and prevention.
Thursday, November 27, 2014
Dramatic Response And Resistance To Cancer Drug Traced
Sequencing reveals why thyroid tumor responded to, and eventually resisted, treatment.
Friday, October 10, 2014
Predicting Cancer’s Next Move
Research offers a new approach to studying drug resistance in cancer.
Monday, November 11, 2013
Understanding Triglycerides’ Role in Coronary Disease
The study leverages new genetic data from a related genome-wide association study, suggests that lowering triglyceride levels through treatment may help reduce the risk of coronary heart disease.
Wednesday, October 09, 2013
Bringing Out the Usual – and Unusual – Cancer Genomics Suspects
Several years ago, researchers sequencing lung cancer genomes encountered a number of red herrings.
Tuesday, June 18, 2013
Chemical Screen Points to New Line of Attack Against Neuroblastoma
In the war on neuroblastoma, the current chemical weaponry is reaching its limit.
Monday, June 10, 2013
Broad Institute, Dana-Farber and Novartis Collaborate to Develop Cancer Cell Line Encyclopedia
Scientists have written the 'Book of Cancer Knowledge' to aid future research into drug discovery and personalized medicine.
Friday, March 30, 2012
Work Flows from Advanced Large-Scale Methods for Measuring Proteins
Researchers have created the most comprehensive “parts list” to date for mitochondria, a compendium that includes nearly 1,100 proteins.
Thursday, July 17, 2008
New Tools Enable Large-Scale Studies of Gene Function
A molecular library created by a research team led by scientists at the Broad Institute of MIT and Harvard has promised to accelerate scientists' understanding of the genetics behind cancer.
Monday, April 10, 2006
Broad Institute Standardizes on Thermo’s MBS Satellite Thermal Cycler
215 additional MBS Satellite thermal cyclers purchased for large-scale genome sequencing and analysis.
Thursday, December 01, 2005
Scientific News
Poor Survival Rates in Leukemia Linked to Persistent Genetic Mutations
For patients with an often-deadly form of leukemia, new research suggests that lingering cancer-related mutations – detected after initial treatment with chemotherapy – are associated with an increased risk of relapse and poor survival.
Marijuana Genome Unraveled
A study by Canadian researchers is providing a clearer picture of the evolutionary history and genetic organization of cannabis, a step that could have agricultural, medical and legal implications for this valuable crop.
Growing Hepatitis C in the Lab
Recent discovery allows study of naturally occurring forms of hepatitis C virus (HCV) in the lab.
Signature of Microbiomes Linked to Schizophrenia
Studying microbiomes in throat may help identify causes and treatments of brain disorder.
Study Identifies the Off Switch for Biofilm Formation
New discovery could help prevent the formation of infectious bacterial films on hospital equipment.
Genetic Overlapping in Multiple Autoimmune Diseases May Suggest Common Therapies
CHOP genomics expert leads analysis of genetic architecture, with eye on repurposing existing drugs.
Fat in the Family?
Study could lead to therapeutics that boost metabolism.
Combo Tool
Joining molecular components expands ability to manipulate genes in specific cell types.
Team Identifies Structure of Tumor-Suppressing Protein
An international group of researchers led by Carnegie Mellon University physicists Mathias Lösche and Frank Heinrich have established the structure of an important tumor suppressing protein, PTEN.
Genes Associated With Improved Survival for Pancreatic Cancer Patients
Use of non-invasive liquid biopsies could predict in which patients the cancer could recur following surgery.
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,500+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
3,700+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FREE!